Pharma stocks crater as investors brace for billions in heartburn drug litigation charges

For many investors and analysts, this ordeal brings back memories of the Bayer Roundup saga.

from Health and Science https://ift.tt/LjxZXGc
https://ift.tt/zsSlgFr
https://ift.tt/3D1j4lb